Joshua Dempster

Joshua Dempster

Harvard University

H-index: 19

North America-United States

About Joshua Dempster

Joshua Dempster, With an exceptional h-index of 19 and a recent h-index of 19 (since 2020), a distinguished researcher at Harvard University, specializes in the field of data science, bioinformatics, cancer biology, machine learning.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract LB203: CRISPR anchor screens to identify co-vulnerabilities and drug combinations in DepMap

PELO is a synthetic lethal target in chromosome 9p21-deleted or MSI cancers

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

DIPG-19. BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA

Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

Abstract LB074: Towards the next generation cancer dependency map

Mapping the landscape of genetic dependencies in chordoma

Joshua Dempster Information

University

Position

Data Scientist, Broad Institute

Citations(all)

2504

Citations(since 2020)

2405

Cited By

804

hIndex(all)

19

hIndex(since 2020)

19

i10Index(all)

25

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Joshua Dempster Skills & Research Interests

data science

bioinformatics

cancer biology

machine learning

Top articles of Joshua Dempster

Abstract LB203: CRISPR anchor screens to identify co-vulnerabilities and drug combinations in DepMap

Cancer Research

2024/4/5

PELO is a synthetic lethal target in chromosome 9p21-deleted or MSI cancers

Cancer Research

2024/3/22

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

Genome Biology

2023/8/23

Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation

2023/6/1

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

Nature Cancer

2023/5

Abstract LB074: Towards the next generation cancer dependency map

Cancer Research

2023/4/14

Mapping the landscape of genetic dependencies in chordoma

Nature Communications

2023/4/6

Charting new cancer dependencies with patient derived organoids

Cancer Research

2023/4/4

A ubiquitination cascade regulating the integrated stress response and survival in carcinomas

Cancer discovery

2023/3/1

Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer

Nature cancer

2022/6

Comparative optimization of combinatorial CRISPR screens

Nature Communications

2022/5/5

A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia

Genes & development

2022/3/1

Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries

bioRxiv

2022/11/19

Transcriptional plasticity drives leukemia immune escape

Blood Cancer Discovery

2022/9/6

Ancestry bias in CRISPR guide design impedes discovery of genetic dependencies

Cancer Research

2022/6/15

Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects

Genome biology

2021/12

Selective modulation of a pan-essential protein as a therapeutic strategy in cancer

Cancer discovery

2021/9/1

See List of Professors in Joshua Dempster University(Harvard University)

Co-Authors

academic-engine